Delivery Order SPE2DB20D7061-SPE2DB25FSPN6
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Celebrex 200 mg capsules (100-count units) with a ceiling value of $3,786.34. This competitive award employs firm fixed pricing under a delivery order contract type with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location....
- The Defense Logistics Agency awarded a $1,507.44 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Celecoxib 200 mg capsules in quantities of 500 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 11, 2025. The award was issued from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters. This delivery...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract valued at $1,857.29 to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, for the provision of 4,557,114,475 units of Celecoxib 200mg in 500-count bottles. This delivery order was issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025, to supply pharmaceuticals and medical supplies...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, under a firm fixed-price contract with a ceiling value of $192,058.56. This non-set-aside delivery order is scheduled for ultimate completion by September 9, 2025, and will be performed at the company's Corporate Office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor,...
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $10,316.76 to AmerisourceBergen Drug Corp on September 1, 2025, with completion targeted for September 2, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $4,181.76 to AmerisourceBergen Drug Corp on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded contract for pharmaceutical products and medical supplies. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $52,252.74 by the Defense Logistics Agency's Medical Supply Chain on September 1, 2025, with a completion date of September 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $16,602.00 to AmerisourceBergen Drug Corp on September 1, 2025, with completion targeted for September 2, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded transaction under the company's existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for pharmaceutical and medical supplies with a ceiling value of $2,819.28. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 25, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. No set-aside designation was utilized for this award. This delivery order is issued...
- AmerisourceBergen Drug Corp was awarded a delivery order contract valued at $41,540.91 by the Defense Logistics Agency's Medical Supply Chain on August 5, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the prime contractor for pharmaceutical and medical supply products. The contract is to be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with completion targeted for August 5, 2025....
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB25FSPN6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Celebrex 200 mg capsules in unit dose packaging (100 count) with a contract value of $6,610.43. This is a firm fixed price delivery order with an ultimate completion date of September 8, 2025, and represents a non-competitive set-aside contract. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its pharmaceutical distribution operations. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. As a prime vendor for the Defense Logistics Agency's Medical Supply Chain, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical commodities to support military and federal healthcare systems worldwide. The company's established IDC vehicle enables flexible fulfillment of critical medication requirements across multiple therapeutic domains for customers including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 9/5/25 |